American Journal of Clinical Nutrition, Vol 50, 353-358, Copyright © 1989 by The American Society for Clinical Nutrition, Inc

REVIEW ARTICLES

Folic acid safety and toxicity: a brief review

CE Butterworth Jr and T Tamura
Department of Nutrition Sciences, University of Alabama, Birmingham 35294.

Oral folic acid (pteroylglutamic acid) is generally regarded as not toxic for normal humans but it may cause neurological injury when given to patients with undiagnosed pernicious anemia. The vitamin should be given with caution to drug-treated epileptic patients because seizure control may be affected. Some studies suggest that folic acid supplements interfere with intestinal zinc absorption in humans and animals but others do not confirm such an effect. The weight of current evidence favors the view that daily supplements of 5-15 mg folic acid do not have significant adverse effects on Zn nutriture in healthy nonpregnant subjects. Because antifolate medications are now being used to treat a wide range of malignant and nonmalignant disorders, further investigation is needed concerning folate metabolism and the safety of supplements in patients with these disorders.

This article has been cited by other articles:

				A. M. Troen, B. Mitchell, B. Sorensen, M. H. Wener, A. Johnston, B. Wood, J. Selhub, A. McTiernan, Y. Yasui, E. Oral, et al. Unmetabolized Folic Acid in Plasma Is Associated with Reduced Natural Killer Cell Cytotoxicity among Postmenopausal Women J. Nutr., January 1, 2006; 136(1): 189 - 194. [Abstract] [Full Text] [PDF]

				R. L Jamison, P. Hartigan, J M. Gaziano, S. P Fortmann, D. S Goldfarb, J. A Haroldson, J. Kaufman, P. Lavori, K. S McCully, and K. Robinson Design and statistical issues in the homocysteinemia in kidney and end stage renal disease (HOST) study Clinical Trials, October 1, 2004; 1(5): 451 - 460. [Abstract] [PDF]

				M. Hansen, S. Samman, L. T Madsen, M. Jensen, S. S Sorensen, and B. Sandstrom Folic acid enrichment of bread does not appear to affect zinc absorption in young women Am. J. Clinical Nutrition, July 1, 2001; 74(1): 125 - 129. [Abstract] [Full Text] [PDF]

				J. F. Gregory III Case Study: Folate Bioavailability J. Nutr., April 1, 2001; 131(4): 1376S - 1382. [Abstract] [Full Text]

				G. SUNDER-PLASSMANN, M. FÖDINGER, H. BUCHMAYER, M. PAPAGIANNOPOULOS, J. WOJCIK, J. KLETZMAYR, B. ENZENBERGER, O. JANATA, W. C. WINKELMAYER, G. PAUL, et al. Effect of High Dose Folic Acid Therapy on Hyperhomocysteinemia in Hemodialysis Patients: Results of the Vienna Multicenter Study J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1106 - 1116. [Abstract] [Full Text]

				H. McNulty, G. J Cuskelly, and M. Ward Response of red blood cell folate to intervention: implications for folate recommendations for the prevention of neural tube defects Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1308S - 1311. [Abstract] [Full Text] [PDF]

				M. E. SULIMAN, J. C. D. FILHO, P. BÀRÀNY, B. ANDERSTAM, B. LINDHOLM, and J. BERGSTROM Effects of High-Dose Folic Acid and Pyridoxine on Plasma and Erythrocyte Sulfur Amino Acids in Hemodialysis Patients J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1287 - 1296. [Abstract] [Full Text]

				M. Achón, L. Reyes, E. Alonso-Aperte, N. Úbeda, and G. Varela-Moreiras High Dietary Folate Supplementation Affects Gestational Development and Dietary Protein Utilization in Rats J. Nutr., June 1, 1999; 129(6): 1204 - 1208. [Abstract] [Full Text]

				N. J Wald and C. Bower Folic acid and the prevention of neural tube defects BMJ, April 22, 1995; 310(6986): 1019 - 1020. [Full Text]

				S. L. Morgan, J. E. Baggott, W. H. Vaughn, J. S. Austin, T. A. Veitch, J. Y. Lee, W. J. Koopman, C. L. Krumdieck, and G. S. Alarcon Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis: A Double-Blind, Placebo-controlled Trial Ann Intern Med, December 1, 1994; 121(11): 833 - 841. [Abstract] [Full Text]